Menu

1 / 23

Vertex Pharmaceuticals Incorporated (VRTX) Q3 2026 Earnings Call Transcript

All Articles on Seeking Alpha·13 days ago
#TAxT9QnG
Reading 0:00
15s threshold

SA Transcripts 162.79K Followers

Q3: 2026-11-02 Earnings Summary

InsightsTranscript Insights EPS of $4.76 misses by $0.02

| Revenue of $3.44B (11.85% Y/Y) beats by $5.82M

Vertex Pharmaceuticals Incorporated (VRTX) Q3 2026 Earnings Call November 2, 2026 4:30 PM EST

Company Participants

Susie Lisa - Senior Vice President of Investor Relations

Reshma Kewalramani - CEO, President & Director

Duncan J. McKechnie - Executive VP & Chief Commercial Officer

Charles Wagner - Executive VP, COO & CFO

Conference Call Participants

Cory Kasimov - Evercore ISI Institutional Equities, Research Division

Jessica Fye - JPMorgan Chase & Co, Research Division

Salveen Richter - Goldman Sachs Group, Inc., Research Division

Geoffrey Meacham - Citigroup Inc., Research Division

Evan Seigerman - BMO Capital Markets Equity Research

Brian Abrahams - RBC Capital Markets, Research Division

Michael Yee - UBS Investment Bank, Research Division

Tazeen Ahmad - BofA Securities, Research Division

Akash Tewari - Jefferies LLC,…

Continue reading — create a free account

Join HashtagPLUS to read full articles, follow hashtags, vote, and join the conversation.